ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Seneca Foods Corp

Seneca Foods Corp (SENEB)

57.51
0.00
(0.00%)
終値: 8月9日 5:00AM
57.51
0.00
( 0.00% )
取引時間後: 5:24AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
57.51
買値
23.18
売値
92.65
出来高
2
59.00 日の範囲 59.00
39.85 52 週間の範囲 64.50
時価総額
前日終値
57.51
始値
59.00
時刻
23
@
59
最終取引時間
05:00:00
財務取引量
-
VWAP
-
平均取引量 (3 か月)
661
発行済株式数
6,964,436
配当利回り
-
PER
6.43
1 株当たり利益 (EPS)
9.09
歳入
1.46B
純利益
63.32M

Seneca Foods Corp について

Seneca Foods Corp is a us-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen and bottled produce and snack chips. It generates maximum revenue from Canned vegetables followed by Frozen vegetables. Seneca Foods Corp is a us-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen and bottled produce and snack chips. It generates maximum revenue from Canned vegetables followed by Frozen vegetables.

セクター
Can Fruit,veg,presrv,jam,jel
業界
Can Fruit,veg,presrv,jam,jel
ウェブサイト
本社
Marion, New York, USA
設立
1970
Seneca Foods Corp is listed in the Can Fruit,veg,presrv,jam,jel sector of the ナスダック市場 with ticker SENEB. The last closing price for Seneca Foods was US$57.51. Over the last year, Seneca Foods shares have traded in a share price range of US$ 39.85 to US$ 64.50.

Seneca Foods currently has 6,964,436 shares in issue. The market capitalisation of Seneca Foods is US$400.52 million. Seneca Foods has a price to earnings ratio (PE ratio) of 6.43.

SENEB 最新ニュース

Advanced Accelerator Applications signs exclusive option and license agreement with FUJIFILM Toyama Chemical to develop and c...

Novel small molecule FF-10158 targets integrin alphavbeta3 (avβ3) and alphavbeta5 (avβ5) receptors Expands theragnostic pipeline  Potential broad application in the detection and treatment of...

Advanced Accelerator Applications Signs Exclusive License Agreement with Cancer Targeted Technology to Develop CTT1057, an F-...

SAINT-GENIS-POUILLY, France, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a Novartis company and leader in nuclear medicine...

Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer

SAINT-GENIS-POUILLY, France, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), a Novartis company and a leader in nuclear...

Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendoc...

First-in-class Therapy Demonstrated 79% Improvement in Progression Free Survival in NETTER-1 Phase 3 Study in Midgut NET Patients Lutathera (lutetium Lu 177 dotatate...

Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer

SAINT-GENIS-POUILLY, France, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), a leader in nuclear medicine theragnostics...

Advanced Accelerator Applications Announces Commencement of Novartis Tender Offer

SAINT-GENIS-POUILLY, France, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today...

Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by Novartis

SAINT-GENIS-POUILLY, France, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today...

Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017

$3.9 Billion All Cash Proposed Tender Offer by Novartis European Approval of Lutetium Lu 177 Dotatate* (Lutathera®) for GEP-NETs Recent Highlights: Sales for the third quarter of 2017...

Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by Novartis

SAINT-GENIS-POUILLY, France, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-2.88-4.7690014903160.3960.821657.3661559.5616043CS
4-3.2-5.2709603030860.7164.557.3687359.90389967CS
12-4.74-7.6144578313362.2564.555.7766160.25074164CS
266.4412.610142941151.0764.54546358.00501324CS
5217.6644.316185696439.8564.539.8548655.30958991CS
1569.0218.601773561648.4971.2531.5141052.07930951CS
26026.2684.03231.2571.2524.7138749.07905941CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MGOLMGO Global Inc
US$ 5.24
(41.62%)
2.24M
MRINMarin Software Incorporated
US$ 2.37
(30.94%)
2.87M
ORGOOrganogenesis Holdings Inc
US$ 3.24
(23.66%)
138
INODInnodata Inc
US$ 19.90
(21.53%)
57.91k
ADMAAdma Biologics Inc
US$ 14.60
(19.77%)
491.39k
CUTRCutera Inc
US$ 0.782
(-30.18%)
99.39k
SKINBeauth Health Company
US$ 0.9102
(-29.44%)
155.05k
MITKMitek Systems Inc
US$ 8.28
(-26.66%)
162.12k
ANTXAN2 Therapeutics Inc
US$ 2.02
(-23.48%)
56.5k
PUBMPubMatic Inc
US$ 15.00
(-23.47%)
131.76k
SOUNSoundHound AI Inc
US$ 5.12
(-1.73%)
13.45M
NVDANVIDIA Corporation
US$ 105.38
(0.39%)
6.32M
CDTConduit Pharmaceuticals Inc
US$ 0.1783
(4.88%)
3.52M
SQQQProShares UltraPro Short QQQ
US$ 9.80
(-0.41%)
3.43M
IOVAIovance Biotherapeutics Inc
US$ 9.30
(17.13%)
3.14M

最近閲覧した銘柄